FDA Approves First mRNA Flu Vaccine for Adults 50+, Updates COVID-19 Vaccines for 2026-2027 Season

The U.S. Food and Drug Administration (FDA) has approved the first mRNA-based influenza vaccine for adults aged 50 and older, marking a significant advancement in flu prevention. Additionally, the FDA has approved four updated COVID-19 vaccines for the upcoming 2026-2027 winter virus season. The Centers for Disease Control and Prevention (CDC) has reissued its 2025-2026 guidance, recommending the seasonal flu shot for everyone aged 6 months and older. RSV vaccines continue to be proven safe and effective.